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Epilepsy is characterized by chronic re c u rre n t
p a roxysmal changes in neurological functions c a u s e d
by abnormalities in the electrical activity of the b r a-
i n1. As epilepsy is considered to involve hypere x c i t a-
ble neurons, a basic assumption in epilepsy re s e a rc h
links the pathogenesis of epilepsy and the gener-
ation of synchronized neuronal activity with an i m-
balance between inhibitory [g-aminobutyric acid
(GABA)-mediated] and excitatory (glutamate-medi-
ated) neurotransmission in favor at the latter2. Ap-
p roximately 2 million persons in the United States
have epilepsy3 , 4 and each year, 100,000 new cases o f
epilepsy are diagnosed in the United States3 , 5. The
most commonly re p o rted etiological factors are s t ro-
ke, tumors, alcohol, head injuries, congenital fac-
tors and neuro i n f e c t i o n s6. In Brazil, neurocysticer-
cosis is the most frequently identified cause of epi-
l e p s y7. Bergen and colleagues8 re p o rted an estima-
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ABSTRACT - Hemodialysis-associated seizure is a complication of hemodialysis. This re p o rt describes the
occurrence of  seizures in patients with end stage renal disease on dialysis therapy at the Nephrology Institu-
te of Mogi das Cruzes, São Paulo State, Brazil. A re t rospective medical history of 189 patients was re v i e w e d
to investigate the occurrence of convulsive seizures during dialytic program. Seven patients with history
of seizures were selected but five of them were included in our study. Three patients presented generali-
zed tonic-clonic seizures, one had partial seizure with secondary generalization, and one presented unclassi-
fied seizure. Three patients presented seizure just during the dialysis (unique seizure) and one of them
p resented convulsive status epilepticus. The two other patients had already presented seizures prior the
beginning of dialysis. We conclude that seizures in renal failure could be considered as occasional events
that do not usually become chronic. 
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O c o rrência de crises epilépticas em pacientes com insuficiência renal crônica em pro g r a m a
dialítico regular
RESUMO - Convulsões durante o tratamento dialítico podem constituir uma complicação da hemodiálise.
Esse artigo descreve a ocorrência de crises em pacientes em estágio final de insuficiência renal crônica sob
tratamento dialítico no Instituto de Nefrologia de Mogi das Cruzes, São Paulo, Brasil. Foram revistos os
p rontuários de 189 pacientes, com o objetivo de investigar a ocorrência de crises convulsivas durante o tra-
tamento dialítico. Dos sete pacientes selecionados com história de crises, cinco concordaram em part i c i p a r
de nosso estudo. Três pacientes apresentaram crises generalizadas tônico-clônicas, um apresentou crise p a r-
cial com generalização subseqüente e um apresentou crise inclassificada. Três pacientes apresentaram crises
apenas durante o processo dialítico (crise única) sendo que um deles apresentou status epilepticus convulsi-
vo. Os outros dois pacientes já haviam apresentado crises antes do início do tratamento dialítico. Nós con-
cluímos que as crises convulsivas que ocorrem em pacientes com falência renal podem ser consideradas c o m o
eventos ocasionais e que usualmente não se tornam crônicas. 
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ted incidence of seizure of approximately 10% in
patients with chronic renal failure. More o v e r, Plum
and Posner9 also noted that convulsions occurred
in one third of patients with end-stage renal dise a s e
(ESRD) and was frequently a pre t e rminal event. T h e
s e i z u res in these series usually were generalized
tonic-clonic type, however, the mechanism of re d u-
ced seizure threshold in renal failure is still u n k n o w n .
Hemodialysis-associated seizure (HAS) is a com-
mon complication of hemodialysis1 0. HAS occurs
in 7% to 50% of children with ESRD, and their sei-
z u res are usually re p o rted as generalized tonic-
clonic seizure s1 1. On the other hand, non-convuls i v e
s e i z u res appear to be rare1 2 , 1 3. Risk factors for HAS
include young age, prior history of seizures, malig-
nant hypertension, microvascular diseases, ure m i c
encephalopathy and card i o m y o p a t h y. More o v e r, i n-
duced brain water disequilibrium, hypocalcaemia,
uremic toxins, the use of acetate in the dialysate,
intracranial hemorrhage due to systemic heparini-
zation, treatment with recombinant ery t ro p o i e t i n ,
hemodinamic and metabolic defects, and dru g s
such as penicillin and theophilline are also conside-
red responsible for HAS1 1 , 1 4 , 1 5. The efficacy of anti-
convulsant drugs in treating or preventing HAS is
not well defined1 0 , 1 6. Diazepam is a non-dialyzable
anticonvulsant dru g1 7 and the administration of
oral diazepam (0.3-0.5 mg/kg per dose) 30 minu-
tes before each hemodialysis session may help to
p revent re c u rrence of HAS1 0. On the other hand,
readily dialyzable antiepileptic drugs such as phe-
nobarbital may increase the risk of HAS1 6 , 1 8. Despite
these observations, several lines of evidence sup-
p o rt the idea that anaemia is one of the major lim-
itations to rehabilitation in patients with ESRD.
The efficacy of recombinant human erithro p o i e t i n
in the treatment of renal anaemia is well establi-
shed. However, this therapeutic approach has been
associated with serious untoward effects: incre a s e d
risk of hypertension, not infrequently accompan i e d
by hypertensive encephalopathy and seizure s1 9 , 2 0.
Based on these facts, the aim of our study was
to investigate the occurrence of seizures in patients
with ESRD under regular hemodialysis program. 
METHOD
A re t rospective medical history of 189 patients was
reviewed to investigate the occurrence of convulsive
s e i z u res in dialysis patients at the Nephrology Institute
of Mogi das Cruzes. From 189 patients under dialytic tre a t-
ment, 7 had suff e red some type of convulsive seizure and
w e re invited to participate in the study, but only 5 patients
had agreed to participate. They were 4 males and 1 fe-
male, with a mean age of 42 years (range 20 to 72 years
old). The five patients have severe systemic arterial hyper-
tension and were using antihypertensive drugs. In our
clinic, all patients have monthly evaluation of total cal-
cium and were receiving aluminum hydroxide. The solu-
tion for the dialytic treatment contains 0.89 gr. of NaCl/5
L, with a calcium concentration of 3.5 mEq/L.
All patients were evaluated for initial disease, dura-
tion, type and frequency of HAS and then submitted to
clinical and neurological examination. The mean time o f
dialysis treatment and the electroencephalography (EEG)
was analysed in all patients. The seizures were classified
a c c o rding the Commission on Classification and Te rm i n o-
logy of International League Against Epilepsy2 1. The pos-
sible seizure triggering factors, such as the use or with-
drawal of medications, sleep deprivation, arterial hyper-
tension, infections, and electrolytic misbalance, especial-
ly hypocalcaemia, were also investigated.
RESULTS
In our study we analyzed the data of 5 out of
189 patients re c ruited under dialytic treatment at
the Nephrology Institute of Mogi das Cruzes. All 5
patients had severe systemic arterial hypert e n s i o n
and were using antihypertensive drugs. These pa-
tients were also using antiepileptic drug (pheni-
toin 200 mg/daily) and CaCO3 (1500 mg/daily). The
mean age of beginning of dialysis was 25 years. T h e
mean duration of dialytic treatment was 5.8 years
(range 2 to 12 years). The causes of renal failure
w e re diabetic nephropathy (4 patients) and chro n-
ic glomerolonephritis (1 patient) (Table 1). All pa-
tients had normal aluminum plasma levels and we-
re not affected by other clinical pictures that could
be led to possible aluminum intoxication. The signs
of Chvostek and Trousseau were absent in all pa-
tients and the neurological examination was nor-
mal in 4 patients, but one presented pyramidal s y n-
d rome (left hemiparesia with pyramidal signs),
with abnormal CT scan (hipodensity on right tem-
poral lobe).
The seizure history of the five patients is listed
on Table 2. Briefly, three patients presented gene-
ralized tonic-clonic seizures, one presented part i a l
Table 1. Causes of renal failure.
Case Age Sex Causes
1 23 Female Chronic glomerulonephritis
2 20 Male Diabetic nephropathy
3 45 Male Diabetic nephropathy
4 44 Male Diabetic nephropathy
5 72 Male Diabetic nephropathy
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s e i z u re. with secondary generalization, and one
p resented unclassified seizure. All patients had sei-
z u res at home, two patients had seizures during
dialysis pro c e d u re and one of them had pre s e n t-
ed convulsive status epilepticus. Two patients had
a l ready presented seizures prior the beginning of
dialysis treatment; one of them without detectable
s t ructural central nervous system lesion, and the
other showed hipodensity on right temporal lobe
(vascular cerebral disease). All patients pre s e n t e d
n o rmal interictal EEG. At time of seizure, none of
them presented infection, electrolytic misbalance
(hypocalcemia), sleep deprivation or were using
theophillin. All patients had anemia and were
using erithropoetin. 
DISCUSSION
Our study evaluated the occurrence of seizure s
in patients with ESRD under hemodialysis pro g r a m .
It has long been believed that seizures are re l a t i v e-
ly common events among patients with systemic d i-
seases. HAS are commonly caused by metabolic e n-
c e p h a l o p a t h y, hypertensive crisis, infection, and
dialysis disequilibrium1 3. We observed the occurre n-
ce of HAS in only 2% of our patients. In this way,
our data are not in agreement with previous studi-
es, which related an estimated incidence of seizure
of approximately 10% in patients with chronic re-
nal failure8. 
The mechanism of reduced seizure thre s h o l d
in renal failure is unknown. One possibility is the
presence of proconvulsive metabolites, including
guanidinosuccinic acid, creatinine, and creatine in
human subjects2 2. More o v e r, the epileptogenic po-
tency of these compounds was further support e d
by animal studies23.
In spite of reports that prior history of seizure
did influence the risk of seizures among patients
receiving hemodialysis1 1, we did not observe high-
er risk in our patients who had prior history of epi-
l e p s y. It is difficult to make comparisons between
our with other studies since diff e rent factors may
influence the analysis, such as the age of the sub-
jects, type of seizures and risk factors for HAS as
previously mentioned.
It has long been believed that in the absence
of prior clinically detected stroke, hypertension, p a r-
ticularly severe and uncontrolled; increase the risk
of unprovoked seizures in older individuals2 4. Con-
v e r s e l y, some studies did not find an association
between hypertension and seizures in the absence
of clinically detected stro k e2 5 , 2 6. In addition, hyper-
tension per se can induce alterations in the human
brain morphology2 7, increasing the risk for clini-
cally apparent brain dysfunction (e.g. epilepsy). In
this way, despite a high prevalence of hypert e n s i-
ve diseases in patients with ESRD and the stro k e
been one of the commonly re p o rted etiological f a c-
tors, just one of our patients that presented seizu-
res had preceding cerebrovascular stroke.
It has also been observed that anaemia is one o f
the major limitations to rehabilitation in patients
with ESRD and the efficacy of recombinant human
e r i t h ropoietin in the treatment of this condition
is well established. All our patients presented anae-
mia and were using erithropoetin. This therapeu-
tic approach has been associated with seizures and
could justify the seizures in our patients that were
using erithropoetin19,20.
At the present moment, the efficacy of antie-
pileptic drugs in treating or preventing HAS is not
well defined. However, the administration of oral
diazepam, a non-dialyzable drug, (0.3 - 0.5 mg/kg
per dose) 30 minutes before each hemodialysis ses-
sion has been shown to prevent the re c u rrence of
H A S1 6. In our study, all patients were using pheni-
toin (200 mg/daily) which is in agreement with
Rust and Chun16, who demonstrated that the use
of phenobarbital, a dialyzable drug, did not pre-
vent the HAS.
Table 2. Seizure history.
Case Seizures during Seizures Type of Frequency 
dialysis procedure at home seizure of seizures
1 Yes Yes Unclassified Five
2 Yes Yes Generalized tonic-clonic Twice
3 No Yes Generalized tonic-clonic Unique
4 No Yes Generalized tonic-clonic Unique
5 No Yes Partial with secondary Unique (SE)
generalization
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We conclude that seizures in renal failure can
be considered as an occasional events that do not
usually become chronic and information on the m a-
nagement of seizures in renal failure should be d i s-
seminated among professionals treating systemic
diseases.
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